Model‐Based Network Meta‐Analysis: A Framework for Evidence Synthesis of Clinical Trial Data
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Model‐based meta‐analysis (MBMA) is increasingly used in drug development to inform decision‐making and future trial designs, through the use of complex dose and/or time course models. Network meta‐analysis (NMA) is increasingly being used by reimbursement agencies to estimate a set of coherent relative treatment effects for multiple treatments that respect the randomization within the trials. However, NMAs typically either consider different doses completely independently or lump them together, with few examples of models for dose. We propose a framework, model‐based network meta‐analysis (MBNMA), that combines both approaches, that respects randomization, and allows estimation and prediction for multiple agents and a range of doses, using plausible physiological dose‐response models. We illustrate our approach with an example comparing the efficacies of triptans for migraine relief. This uses a binary endpoint, although we note that the model can be easily modified for other outcome types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Checking consistency in mixed treatment comparison meta-analysis
Dias, S., Welton, N. J., Caldwell, D. M., & Ades, A. E. (2010) · Statistics in Medicine · doi:10.1002/sim.3767 · Cited by 2,521 · cited 1×
“of assessing the agreement between both types of evidence.(8) Although model estimates of treatment effects will”
Self-citationDias, S., Sutton, A. J., Ades, A. E., & Welton, N. J. (2013) · Medical Decision Making · doi:10.1177/0272989x12458724 · Cited by 1,207
Self-citationLearning versus confirming in clinical drug development*
Sheiner, L. B. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90160-0 · Cited by 633
Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development
Milligan, P. A., Brown, M. J., Marchant, B., Martin, S. W., van der Graaf, P. H., Benson, N., Nucci, G., Nichols, D. J., Boyd, R. A., Mandema, J. W., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.54 · Cited by 238
Bayesian Measures of Model Complexity and Fit
Spiegelhalter, D. J., Best, N. G., Carlin, B. P., & Van Der Linde, A. (2002) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00353 · Cited by 151
Cited by
Gallardo-Gómez, D., del Pozo-Cruz, J., Noetel, M., Álvarez-Barbosa, F., Alfonso-Rosa, R. M., & del Pozo Cruz, B. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101591 · Cited by 268
“We used a random-effects Bayesian Model-Based Network Meta-Analysis (MBNMA) (Mawdsley et al., 2016) to summarize the dose-response association between exercise dose and cognition.”
Network meta‐analysis of multicomponent interventions
Rücker, G., Petropoulou, M., & Schwarzer, G. (2020) · Biometrical Journal · doi:10.1002/bimj.201800167 · Cited by 195
Marshall, S., Madabushi, R., Manolis, E., Krudys, K., Staab, A., Dykstra, K., & Visser, S. A. G. (2019) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12372 · Cited by 138
Zhang, Y. S., Weng, W. Y., Xie, B. C., Meng, Y., Hao, Y. H., Liang, Y. M., & Zhou, Z. K. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4649-8 · Cited by 93
Gallardo-Gómez, D., del Pozo-Cruz, J., Pedder, H., Alfonso-Rosa, R. M., Álvarez-Barbosa, F., Noetel, M., Jasper, U., Chastin, S., Ramos-Munell, J., & del Pozo Cruz, B. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2022-106409 · Cited by 59
Metadata
- Authors
- Mawdsley, D., Bennetts, M., Dias, S., Boucher, M., & Welton, N.
- Venue
- CPT: Pharmacometrics & Systems Pharmacology
- Publisher
- Wiley
- Published
- 2016-08
- Volume
- 5
- Issue
- 8
- Pages
- 393-401
- ISSN
- 2163-8306 (ISSN-L)
- OpenAlex
- W2496836908
- Cited by
- 170
- References
- 5
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Model‐Based Network Meta‐Analysis: A Framework for Evidence Synthesis of Clinical Trial Data. https://app.cochat.ai/papers/10.1002/psp4.12091
- The paper
- Mawdsley, D., Bennetts, M., Dias, S., Boucher, M., & Welton, N. (2016). Model‐Based Network Meta‐Analysis: A Framework for Evidence Synthesis of Clinical Trial Data. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.12091
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.